These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 203426

  • 1. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
    Gergely P, Ernberg I, Klein G, Steinitz M.
    Clin Exp Immunol; 1977 Dec; 30(3):347-53. PubMed ID: 203426
    [Abstract] [Full Text] [Related]

  • 2. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 3. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM.
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [Abstract] [Full Text] [Related]

  • 4. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 5. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA.
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [Abstract] [Full Text] [Related]

  • 6. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 7. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M.
    N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884
    [Abstract] [Full Text] [Related]

  • 8. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May 22; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 9. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD, Patel J, Schwab H, Martinez J.
    Cytometry B Clin Cytom; 2003 Sep 22; 55(1):22-8. PubMed ID: 12949956
    [Abstract] [Full Text] [Related]

  • 10. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Sep 22; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT, Bluestein HG, Zvaifler NJ.
    J Immunol; 1985 Apr 22; 134(4):2287-93. PubMed ID: 2857749
    [Abstract] [Full Text] [Related]

  • 12. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes.
    Tosato G, Magrath IT, Koski IR, Dooley NJ, Blaese RM.
    J Clin Invest; 1980 Aug 22; 66(2):383-8. PubMed ID: 6249850
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
    Chu ET, Lareau M, Rosenwasser LJ, Dinarello CA, Geha RS.
    J Immunol; 1985 Mar 22; 134(3):1676-81. PubMed ID: 2981918
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.
    Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. B lymphocytopenia in infectious mononucleosis.
    Sumaya CV, Keightley RG.
    Clin Exp Immunol; 1981 Feb 15; 43(2):298-301. PubMed ID: 6268336
    [Abstract] [Full Text] [Related]

  • 18. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M.
    Hokkaido Igaku Zasshi; 1986 Jul 15; 61(4):584-92. PubMed ID: 3019855
    [Abstract] [Full Text] [Related]

  • 19. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.
    Depper JM, Bluestein HG, Zvaifler NJ.
    J Immunol; 1981 Nov 15; 127(5):1899-902. PubMed ID: 6271870
    [Abstract] [Full Text] [Related]

  • 20. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR, McNaughton ME, Cooper NR.
    J Immunol; 1985 Nov 15; 135(5):3068-73. PubMed ID: 2995485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.